Bank of America Securities Maintains Buy Rating for Thermo Fisher with $545 Price Target

Bank of America Securities analyst Michael Ryskin maintains a Buy rating for Thermo Fisher with a $545 price target. The company's shares closed at $424.98. Ryskin covers the Healthcare sector and has a 50.91% success rate on recommended stocks. Thermo Fisher has a one-year high of $627.88 and a one-year low of $385.46.

Thermo Fisher Scientific Inc. (TMO) has seen a strong bullish consensus among analysts, with 16 out of 19 analysts rating the stock as a "Buy" or "Strong Buy" in the past three months [1]. The average price target for TMO is $546.72, representing a 31.33% upside from its current price of $416.31 [1].

Michael Ryskin, a Bank of America Securities analyst, maintains a "Buy" rating for TMO with a price target of $545 [1]. Ryskin has a 50.91% success rate on recommended stocks and covers the Healthcare sector [1]. Despite the economic pressures, analysts believe TMO's focus on innovation and acquisitions positions it for sustained growth.

The company's shares closed at $424.98 on July 2, 2025, with a one-year high of $627.88 and a one-year low of $385.46 [1]. The next quarter's earnings estimate for TMO is $5.23, with a range of $5.19 to $5.29, and the sales forecast is $10.68B, with a range of $10.49B to $10.76B [1].

References:
[1] https://www.tipranks.com/stocks/tmo/forecast